Pet Valu Offers New Purchasing Options, Limits In-Store Customers and Updates Store Hours
Pet Valu, considered an essential service, announces new store operations, including phone orders to ensure safety of its community
MARKHAM, ON, March 30, 2020 /CNW/ - Classified as an essential service, Pet Valu, a specialty retailer of premium pet food, treats and supplies is committed to remaining open to ensure pet parents can continue to purchase the food and supplies they need. To support this mission, Pet Valu has announced temporary changes to store operations to limit the physical interactions between associates and customers, as well as ensure the continued safe operation of all stores.
To ensure the community's safety, Pet Valu stores have implemented the following:
Customers can now call their store to place their order by phone. Orders are then filled and ready for pick-up.
Limiting the number of customers that can enter the store at any time to two (for safe social distancing).
Shortening hours of operation to allow associates time to re-stock and sanitize stores (store hours may vary, so customers should call their local store for more information).
Currently not accepting returns and extending the return policy period. Customers are being asked to keep the item(s) intended for return and associated receipt(s) until further notice.
All customers are asked to have a list or photos of supplies ready, so that associates can help retrieve products. Customers will be directed to wait at the sanitized checkout counter to complete all in-store transactions. (Debit or credit is preferred at checkout; please note that some stores are no longer accepting cash at this time).
Temporarily closing all self-serve dog wash stations and grooming salons.
Cancelling all local events and postponing its annual Pet Appreciation Month and National Adoption Weekend, supporting local animal shelters and rescues.
"We believe taking these actions offer the best solutions for balancing our three main priorities: safety of our associates and devoted pet lover customers, servicing the essential needs of pets and maintaining a clean and sanitized work environment," says Richard Maltsbarger, president and CEO of Pet Valu. "I want to thank all of our associates and customers for working together through this difficult time to find the best ways possible to continue to care for the pets we all love."
Pet Valu is closely following all regulations regarding COVID-19 and continually keeping the safety and health of associates and customers top of mind. Visit petvalu.com for more information and updates.
About Pet Valu Pet Valu, Inc. is a Canadian specialty retailer of pet food and pet-related supplies with more than 588 stores across Canada. The Pet Valu family of stores consists of Pet Valu Canada, Paulmac's Pet Foods, Bosley's by Pet Valu, Total Pet, and Tisol Pet Nutrition & Supply stores. To learn more about Pet Valu visit petvalu.com.
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...